In this review we present an overview of quality of life (QOL) and QOL measures in
neuromuscular disorders. We discuss the characteristics of QOL measures used in …

Background Myasthenia gravis (MG) leads to exertion-dependent muscle weakness, but
also psychological and social well-being are limited. We aim to describe the burden of …

This study aimed to review studies focused on the affective comorbidities associated with
myasthenia gravis and to determine the extent to which neuromuscular treatment modalities …

We describe the process whereby a recently developed myasthenia gravis (MG)‐specific
quality‐of‐life (QOL) instrument was reduced from 60 items to 15 items while maintaining …

The recommendations for clinical research standards published in 2000 by a task force of
the Medical Scientific Advisory Board (MSAB) of the Myasthenia Gravis Foundation of …

Background Myasthenia gravis (MG) is a chronic neuromuscular disease. Advances in
medical therapy have continuously increased the life expectancy of MG patients, without …

We performed a community-based survey of 165 Australian patients with a physician-
confirmed diagnosis of myasthenia gravis (MG). MG is an autoimmune disease of the …

Objectives Myasthenia gravis (MG) is a rare, chronic, autoimmune neuromuscular disease
which can affect functional and mental aspects of health and health-related quality of life …

We assessed the performance of items from the Quantitative Myasthenia Gravis (QMG),
MMT (Manual Muscle Test), and MG‐ADL (Myasthenia Gravis–Activities of Daily Living) …

Introduction: Our study aim was to produce a Japanese translation of the 15‐item
Myasthenia Gravis Quality‐of‐Life Scale (MG‐QOL15), assess its reliability and validity, and …